Clinical Trials Directory

Trials / Completed

CompletedNCT03224910

Diagnostic Efficiency of Touch Imprints Versus Smears

Diagnostic Efficiency of Needle Core Biopsy Touch Imprints Versus Fine Needle Aspiration Smears at the Time of Rapid on Site Interpretation

Status
Completed
Phase
Study type
Observational
Enrollment
47 (actual)
Sponsor
University of Mississippi Medical Center · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Cytopathologists work along with radiologist in the diagnosis of lesions. Rapid on site interpretation (ROSE) of fine needle aspiration (FNA) smears of radiologically suspicious lesions is a common clinical practice. In the last years, the investigators have seen trend towards needle core biopsies of radiologically suspicious lesions. The investigators want to analyze the challenges of rapid on site interpretation of touch imprints (TI) of needle core biopsies (NCB) versus fine needle aspiration smears.

Detailed description

This is a retrospective study in which the investigators will analyze the quality of the smears and the touch imprints, the cellularity, the cytomorphologic features of the specimens and the presence of adequate material for ancillary studies. The specimens will be searched through the University of Mississippi Medical Center's Pathology Laboratory information system (Copath), from January 2011 to December 2017. The retrospective cases (January 2011 up to now) will be retrieved using natural language search of fine needle aspiration and touch imprints. The slides of those cases will be reviewed and the cytomorphologic features will be described.

Conditions

Interventions

TypeNameDescription
OTHERCytologic techniques used for rapid on site interpretationDiagnostic efficiency of touch imprints of needle core biopsies vs smears of fine needle aspirations during rapid on-site interpretation

Timeline

Start date
2017-07-18
Primary completion
2018-05-02
Completion
2018-05-02
First posted
2017-07-21
Last updated
2018-05-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03224910. Inclusion in this directory is not an endorsement.